Trio-Tech International’s (TRT Quick QuoteTRT - Free Report) investors have been experiencing some short-term losses from the stock lately. Shares of the Van Nuys, CA-based provider of semiconductor back-end solutions and a value-added supplier of electronic equipment plunged 64.1% in the past six months compared with the industry’s 13.8% decline. It has also underperformed the sector’s gain of 4.4% and the S&P 500’s rise of 5.2% in the same time frame.

Recent developments at Trio-Tech include the receipt of a new three-year contract valued at approximately $4.45 million to provide burn-in testing equipment and ongoing technical and maintenance support to an existing European automotive semiconductor customer (this month) and the announcement of its fourth-quarter fiscal 2026 results (in September).

Trio-Tech’s fourth-quarter fiscal 2026 performance reflected strong revenue growth, driven by increased semiconductor testing activity. Demand for AI-related and automotive semiconductor testing supported the Semiconductor Back-End Solutions (SBS) segment, while the Industrial Electronics (IE) segment experienced softer quarterly sales. A growing order backlog, expanded testing capacity in Malaysia and a new multiyear EV semiconductor burn-in contract strengthened TRT’s growth prospects heading into fiscal 2027.

However, profitability remained under pressure, with Trio-Tech reporting a quarterly operating loss and a net loss attributable to common shareholders. A greater contribution from lower-margin semiconductor testing services weighed on gross margins, while higher operating expenses further constrained earnings. Continued pressure from an unfavorable revenue mix and elevated corporate costs could limit profitability despite robust semiconductor demand.

TRT’s Six-Month Price Comparison

Image Source: Zacks Investment Research

Over the past six months, the stock’s performance has remained weak, underperforming its peers like Aehr Test Systems (AEHR Quick QuoteAEHR - Free Report) and InTest Corporation (INTT Quick QuoteINTT - Free Report) . Aehr and InTest’s shares have lost 38.7% and 21.8%, respectively, in the same time frame.

Despite margin pressure from a greater mix of lower-margin semiconductor testing services and elevated operating expenses, Trio-Tech’s favorable demand outlook, expanding backlog, increased testing capacity in Malaysia and focus on operational efficiency and disciplined capital allocation position it to benefit from growing semiconductor testing demand.

The favorable share price movement suggests investors remain optimistic about TRT's ability to sustain its recent business momentum.

Trio-Tech operates as a global one-stop solutions provider, designing and manufacturing semiconductor reliability test systems, providing comprehensive testing services, and offering value-added distribution and industrial electronics solutions across diverse end markets.

TRT's Semiconductor Demand and Expanding Orders

Trio-Tech continues to benefit from growing demand for semiconductor reliability testing associated with AI and high-performance computing. The company secured successive orders for high-performance burn-in boards supporting a next-generation AI GPU platform during fiscal 2026. These orders demonstrate its ability to support increasingly complex semiconductor devices as customers scale advanced computing programs. Sustained demand for AI-related testing services also contributed to significant growth in the SBS business.

Trio-Tech expanded its automotive semiconductor presence through a multiyear production burn-in agreement with a new global integrated device manufacturer in September 2026. The agreement marks its second EV semiconductor production burn-in customer. A separate October contract for burn-in equipment and ongoing technical support further strengthened an established European customer relationship. These agreements reinforce TRT's capabilities in meeting stringent automotive reliability standards while providing recurring business opportunities and greater revenue visibility.

Trio-Tech's expanded facility in Perai, Penang, strengthens its operational infrastructure and ability to support large-scale semiconductor testing programs. The company is progressively installing system-level and electrical testing capabilities, with production volumes expected to increase beginning in the second quarter of fiscal 2027. The additional facility space provides greater operational flexibility as testing activities expand across Southeast Asia. Successful execution of the phased installation should support higher throughput and improve TRT's ability to accommodate evolving customer requirements.

Trio-Tech’s Diversification and Financial Flexibility

Trio-Tech's IE segment is benefiting from expanding aerospace-related product sales and improving distribution activity. Encouraging bookings entering fiscal 2027 reflect customer interest across aerospace, display solutions and other industrial markets. The company is also exploring data center and industrial energy-efficiency applications, including equipment designed to improve cooling-tower performance while reducing water and energy consumption. These initiatives could diversify TRT's revenue streams and reduce its historical dependence on the semiconductor industry.

Trio-Tech's financial position strengthened during fiscal 2026, supported by higher cash balances, improved operating cash generation and increased working capital. Stronger operating cash flow reflected favorable working capital movements and improved business activity, while TRT also reduced outstanding bank borrowings. Its liquidity position provides flexibility to manage near-term obligations, absorb industry volatility and pursue strategic opportunities. This financial cushion supports management's emphasis on disciplined capital allocation without excessive reliance on external financing.

Challenges Ahead of TRT

Trio-Tech faces persistent margin pressure as its growing reliance on lower-margin semiconductor final testing services weighs on profitability despite increasing business volumes. This unfavorable revenue mix, coupled with elevated personnel and corporate expenses, could constrain operating earnings. Additionally, increasing customer concentration poses risks, as a substantial portion of revenue depends on a major U.S.-based customer. Any reduction in testing demand, changes in sourcing strategies or delays in customer programs could adversely affect revenue stability and operational performance.

Trio-Tech Stock’s Valuation

TRT's trailing 12-month EV/Sales of 0.4X is lower than the industry’s average of 6.7X but is higher than its five-year median of 0.2X.

Image Source: Zacks Investment Research

Aehr and InTest’s trailing 12-month EV/Sales currently stand at 33.8X and 1.2X, respectively, in the same time frame.

Our Final Take on TRT

Trio-Tech’s steep share-price decline over the past six months contrasts with the improving business opportunities and growth initiatives that support its longer-term outlook. Although the company is making progress in strengthening its market position and expanding its operational capabilities, the benefits of these initiatives may take time to translate into consistent profitability. This disconnect between business momentum and stock performance suggests that investors remain cautious about TRT’s ability to deliver sustainable earnings growth.

From a valuation perspective, TRT trades at a substantial discount to the broader industry, which could appeal to investors seeking exposure to its long-term growth potential. However, its valuation remains above its historical median, indicating that the stock may not necessarily be undervalued despite the sharp correction. This mixed valuation picture suggests that the recent selloff may not automatically represent an attractive buying opportunity. A sustained recovery may depend on improving profitability, effective execution of expansion initiatives and stronger earnings visibility.

Overall, Trio-Tech offers encouraging long-term growth prospects, although near-term execution uncertainties warrant caution. Existing investors may consider holding their positions while monitoring profitability improvements, whereas prospective investors may prefer to wait for clearer earnings visibility and a more compelling valuation before initiating positions.